Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAH - 21-Hydroxylase Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05128942
What this trial is testing

Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH

Who this might be right for
Congenital Adrenal Hyperplasia21-OHD
Spruce Biosciences 67
Not applicableUnknownNCT05162950
What this trial is testing

Effects and Importance of Epinephrine/Adrenalin Deficiency in CAH

Who this might be right for
Congenital Adrenal Hyperplasia
Region Stockholm 120
Early research (Phase 1)Ended earlyNCT02574910
What this trial is testing

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

Who this might be right for
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT07187375
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old

Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine Switzerland GmbH 7
Not applicableStudy completedNCT00542841
What this trial is testing

Examining Genetic Differences Among People With 21-Hydroxylase Deficiency

Who this might be right for
21-hydroxylase Deficiency
Maria I. New 99
Testing effectiveness (Phase 2)WithdrawnNCT03548246
What this trial is testing

Androgen Reduction in Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT03525886
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia

Who this might be right for
CAH - Congenital Adrenal Hyperplasia
Neurocrine Biosciences 18
Not applicableStudy completedNCT03550261
What this trial is testing

Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia (CAH)
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT01859312
What this trial is testing

Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia

Who this might be right for
Adrenal InsufficiencyExcess AndrogenCongenital Adrenal Hyperplasia (CAH)
National Institutes of Health Clinical Center (CC) 8
Not applicableStudy completedNCT01807364
What this trial is testing

Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
Assistance Publique - Hôpitaux de Paris 170
Not applicableStudy completedNCT06449456
What this trial is testing

Exercise Capacity, Physical Fitness, and Physical Activity Levels in Children With CAH

Who this might be right for
Congenital Adrenal HyperplasiaExercise CapacityPhysical Activity+1 more
Hacettepe University 48
Not applicableLooking for participantsNCT00250159
What this trial is testing

Natural History Study of Patients With Excess Androgen

Who this might be right for
Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3,000
Early research (Phase 1)Not Yet RecruitingNCT07811089
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OMS1620

Who this might be right for
Congenital Adrenal Hyperplasia (CAH)
OMass Therapeutics Australia Proprietary Ltd 84
Large-scale testing (Phase 3)Looking for participantsNCT07144163
What this trial is testing

Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc. 150
Not applicableLooking for participantsNCT07473804
What this trial is testing

Syndromes With Neonatal Salt Loss: Not Only Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency (21OH-ISC)

Who this might be right for
Neonatal Salt LossCongenital Adrenal Hyperplasia (CAH)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 25
Testing effectiveness (Phase 2)Looking for participantsNCT06712823
What this trial is testing

An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc. 200
Not applicableLooking for participantsNCT06754423
What this trial is testing

Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency

Who this might be right for
Congenital Adrenal Hyperplasia
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Testing effectiveness (Phase 2)Study completedNCT02804178
What this trial is testing

ATR-101 for the Treatment of Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
Millendo Therapeutics, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT07159841
What this trial is testing

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Who this might be right for
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc. 153
Testing effectiveness (Phase 2)Ended earlyNCT04544410
What this trial is testing

A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH

Who this might be right for
Congenital Adrenal Hyperplasia
Spruce Biosciences 100
Next Page